These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34698613)

  • 1. Indicators of publicly funded prescription opioid use among persons with traumatic spinal cord injury in Ontario, Canada.
    Guan Q; Calzavara A; Cadel L; Hogan ME; McCormack D; Patel T; Lofters AK; Hitzig SL; Guilcher SJT
    J Spinal Cord Med; 2023 Nov; 46(6):881-888. PubMed ID: 34698613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of prescribed opioid claims among persons with nontraumatic spinal cord dysfunction in Ontario, Canada: a population-based retrospective cohort study.
    Guan Q; Hogan ME; Calzavara A; McCormack D; Lofters AK; Patel T; Hitzig SL; Packer T; Guilcher SJT
    Spinal Cord; 2021 May; 59(5):512-519. PubMed ID: 33495578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Prescribed Opioid Claims Among Persons With Traumatic Spinal Cord Injury in Ontario, Canada: A Population-Based Retrospective Cohort Study.
    Guilcher SJT; Hogan ME; Guan Q; McCormack D; Calzavara A; Patel T; Hitzig SL; Packer T; Lofters AK
    Arch Phys Med Rehabil; 2021 Jan; 102(1):35-43. PubMed ID: 32891422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription drug claims following a traumatic spinal cord injury for older adults: a retrospective population-based study in Ontario, Canada.
    Guilcher SJT; Hogan ME; Calzavara A; Hitzig SL; Patel T; Packer T; Lofters AK
    Spinal Cord; 2018 Nov; 56(11):1059-1068. PubMed ID: 30065350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription medications dispensed following a nontraumatic spinal cord dysfunction: a retrospective population-based study in Ontario, Canada.
    Guilcher SJT; Hogan ME; McCormack D; Calzavara AJ; Hitzig SL; Patel T; Packer T; Guan Q; Lofters AK
    Spinal Cord; 2021 Feb; 59(2):132-140. PubMed ID: 32665709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study.
    Gomes T; Juurlink DN; Antoniou T; Mamdani MM; Paterson JM; van den Brink W
    PLoS Med; 2017 Oct; 14(10):e1002396. PubMed ID: 28972983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inequities in access to primary care among opioid recipients in Ontario, Canada: A population-based cohort study.
    Gomes T; Campbell TJ; Martins D; Paterson JM; Robertson L; Juurlink DN; Mamdani M; Glazier RH
    PLoS Med; 2021 Jun; 18(6):e1003631. PubMed ID: 34061846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of high-risk opioid use metrics among individuals with spinal cord injury: A brief report.
    DiPiro ND; Murday D; Krause JS
    J Spinal Cord Med; 2023 Jul; 46(4):687-691. PubMed ID: 37318872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Interdisciplinary Approach to Reducing Opioid Prescriptions to Patients with Chronic Pain in a Spinal Cord Injury Center.
    Brose SW; Schneck H; Bourbeau DJ
    PM R; 2019 Feb; 11(2):135-141. PubMed ID: 30266347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Use Among Individuals With Spinal Cord Injury: Prevalence Estimates Based on State Prescription Drug Monitoring Program Data.
    DiPiro ND; Murday D; Corley EH; DiPiro TV; Krause JS
    Arch Phys Med Rehabil; 2021 May; 102(5):828-834. PubMed ID: 33227268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Prescription Opioid Use 4 Months After Traumatic Musculoskeletal Injury and Corrective Surgery: A Prospective Study.
    Rosenbloom BN; McCartney CJL; Canzian S; Kreder HJ; Katz J
    J Pain; 2017 Aug; 18(8):956-963. PubMed ID: 28347798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of other opioids during methadone therapy: a population-based study.
    Kurdyak P; Gomes T; Yao Z; Mamdani MM; Hellings C; Fischer B; Rehm J; Bayoumi AM; Juurlink DN
    Addiction; 2012 Apr; 107(4):776-80. PubMed ID: 22050078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the population-level effects of oxycodone restrictions on prescription opioid utilization in Ontario.
    Rudoler D; Kurdyak P; Gomes T; Huang A; Jones W; Littleford S; Paracha N; Fischer B
    Pharmacoepidemiol Drug Saf; 2022 Jul; 31(7):769-778. PubMed ID: 35470515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription opioids for occupational injury: results from workers' compensation claims records.
    Berecki-Gisolf J; Collie A; McClure RJ
    Pain Med; 2014 Sep; 15(9):1549-57. PubMed ID: 24641213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in opioid use and dosing among socio-economically disadvantaged patients.
    Gomes T; Juurlink DN; Dhalla IA; Mailis-Gagnon A; Paterson JM; Mamdani MM
    Open Med; 2011; 5(1):e13-22. PubMed ID: 22046214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term analgesic use after low-risk surgery: a retrospective cohort study.
    Alam A; Gomes T; Zheng H; Mamdani MM; Juurlink DN; Bell CM
    Arch Intern Med; 2012 Mar; 172(5):425-30. PubMed ID: 22412106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Publicly funded home care service use in the first 2 years after spinal cord injury in Ontario, Canada.
    Chan BC; Cronin S; Jaglal SB; Craven BC
    Home Health Care Serv Q; 2020; 39(2):95-106. PubMed ID: 32009576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of long-term use of prescription opioids in the community-dwelling population of adults without a cancer diagnosis: a retrospective cohort study.
    Béliveau A; Castilloux AM; Tannenbaum C; Vincent P; de Moura CS; Bernatsky S; Moride Y
    CMAJ Open; 2021; 9(1):E96-E106. PubMed ID: 33563639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose and Duration of Opioid Use in Propensity Score-Matched, Privately Insured Opioid Users With and Without Spinal Cord Injury.
    Hand BN; Krause JS; Simpson KN
    Arch Phys Med Rehabil; 2018 May; 99(5):855-861. PubMed ID: 29307814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of delisting high-strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada.
    Martins D; Khuu W; Tadrous M; Juurlink DN; Mamdani MM; Paterson JM; Gomes T;
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):726-733. PubMed ID: 30873707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.